Diagnostic Substances Stocks in News (Trinity Biotech plc, Neogen Corporation, Atossa Genetics Inc, Quidel Corporation)

Las Vegas, NV -- (SBWIRE) -- 02/26/2013 -- Cogonews.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-

Trinity Biotech plc (ADR) (NASDAQ:TRIB) shares decreased 0.82% and closed at $16.84. Trinity Biotech plc (Trinity Biotech)develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Can TRIB Recover After The Recent fall? Find Out Here

Neogen Corporation (NASDAQ:NEOG) shares declined 1.27% to $46.59. Neogen Corporation (Neogen), together with its subsidiaries, develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. It is engaged in developing and marketing test kits that provide food safety solutions.

Can NEOG Recover Now? Find Out Here

Atossa Genetics Inc (NASDAQ:ATOS) shares lost 5.59% and closed at $6.54. Atossa Genetics Inc. is a development-stage healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.

How Should Investors Trade ATOS Now? Find Out Here

Quidel Corporation (NASDAQ:QDEL) stock decreased 0.98% to $22.21. Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases.

Get Free Trend Analysis on To Know More About PAY Here

About Cogo News
Cogonews.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by cogonews.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. cogonews.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
cogonews.com
editor@cogonews.com